Showing results (1951-1960 of 2,389) with videos related to
Sort By:
Pageof 239
BMC Gastroenterology|May 26, 2009
Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control studyHuang-Ming Hu, Chao-Hung Kuo, Chien-Hung Lee, et al.Biomaterials|May 27, 2009
The effect of BisGMA on cyclooxygenase-2 expression, PGE2 production and cytotoxicity via reactive oxygen species- and MEK/ERK-dependent and -independent pathwaysMei-Chi Chang, Li-Deh Lin, Chiu-Po Chan, et al.Future Oncology (London, England)|January 18, 2020
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinomaMichael R Migden, Sunandana Chandra, Guilherme Rabinowits, et al.Therapeutic Advances in Gastroenterology|February 6, 2018
Insights into the management of gastric antral vascular ectasia (watermelon stomach)Wen-Hung Hsu, Yao-Kuang Wang, Meng-Shu Hsieh, et al.Surgical Innovation|December 31, 2020
Development of an Intraoperative Pipeline for Holographic Mixed Reality Visualization During Spinal Fusion SurgeryVivek P Buch, Kobina G Mensah-Brown, James W Germi, et al.Plos Genetics|December 28, 2021
Delta/Jagged-mediated Notch signaling induces the differentiation of agr2-positive epidermal mucous cells in zebrafish embryosYu-Fen Lu, Da-Wei Liu, I-Chen Li, et al.Journal of Biomedicine & Biotechnology|November 6, 2012
The plasminogen receptor, Plg-R(KT), and macrophage functionLindsey A Miles, Shahrzad Lighvani, Nagyung Baik, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 16, 2025
GKB202 suppresses endothelin-1/ERK signaling in pancreatic cancer cells: Potential implications for circulating tumor cell regulationYu-Fang Hu, Andy Y Chen, Jun-Way Chang, et al.Current Developments in Nutrition|December 3, 2024
Metabolites Link Intake of a Healthy Diet to Better Insulin and Glucose Homeostasis in the Microbiome and Insulin Longitudinal Evaluation Study (MILES)Alexis C Wood, Danielle J Lee, Patricia A Sheridan, et al.Targeted Oncology|October 11, 2024
Taiwan Nationwide Study of First-Line ALK-TKI Therapy in ALK-Positive Lung AdenocarcinomaZhe-Rong Zheng, Jia-Jun Wu, Chun-Ju Chiang, et al.Pageof 239